Potential role of Anxa1 in cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Annexins are a superfamily of Ca(2+)-regulated, phospholipid-binding proteins.
• Annexin A1 (Anxa1) is involved in crucial cellular processes including inflammation, proliferation, and apoptosis.
• Anxa1 deregulation is implicated in various aspects of cancer, including development, invasion, metastasis, and drug resistance.

Purpose of the Study:

• To summarize the current understanding of the association between Anxa1 and malignant tumors.
• To explore the potential mechanisms by which Anxa1 influences cancer progression.
• To evaluate the potential of Anxa1 as a biomarker for cancer diagnosis, treatment, and prognosis.

Main Methods:

• Literature review of recent research on Anxa1 and cancer.
• Analysis of studies investigating the dual role of Anxa1 (suppressor vs. promoter) in different cancer types.
• Synthesis of evidence regarding Anxa1's involvement in cancer-related biological processes.

Main Results:

• Anxa1 exhibits context-dependent functions, potentially acting as a tumor suppressor or promoter in different cancers.
• Anxa1 deregulation is frequently observed in malignant tumors, correlating with disease progression and therapeutic resistance.
• Evidence suggests Anxa1's involvement in key cancer hallmarks such as cellular signaling, membrane dynamics, and immune response.

Conclusions:

• Anxa1 is a significant factor in cancer biology with a complex, often opposing, role.
• Understanding Anxa1's specific functions in different tumor types is crucial for therapeutic targeting.
• Anxa1 holds promise as a valuable biomarker for improving cancer diagnosis, treatment strategies, and patient prognosis.